This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Everything you need to know about CJC-1295 with DAC dosing — protocols, safety, and where to buy.
Dose Range
1,000–2,000 mcg (1–2 mg) per injection
Frequency
Once per week
Cycle Length
8–12 weeks with 4 week breaks
Half-Life
6–8 days (due to albumin binding via DAC)
Calculate syringe units instantly
Syringe Draw
10.0 units
2500 mcg/ml · 0.100 ml draw
Contraindications
Active cancer. Pituitary disorders. Diabetes (GH affects insulin sensitivity). Pregnancy or breastfeeding.
Due to long half-life, once-weekly dosing is sufficient. The continuous GH elevation may blunt natural pulsatile release over time. Some practitioners prefer the non-DAC version (mod GRF 1-29) for this reason. Monitor fasting glucose and IGF-1 levels periodically.
The typical dose range for CJC-1295 with DAC is 1,000–2,000 mcg (1–2 mg) per injection. It is usually administered Once per week. Always start with the lowest effective dose.
Once per week
Yes, typical cycle length is 8–12 weeks with 4 week breaks.
Similar to CJC-1295 but with potential for more sustained side effects due to DAC half-life extension. Injection site reactions, water retention, numbness, joint stiffness, constant (non-pulsatile) GH elevation concerns.
Visit our vendor directory to find trusted sources for CJC-1295 with DAC.